Projected uptake of sulfadoxine–pyrimethamine for perennial malaria chemoprevention in children under 2 years of age in nine sub-Saharan African countries: an epidemiologically-based 5-year forecast analysis

Table 2 Forecast model inputs to estimate the number of children eligible for PMC in 2023 and growth projections

Country	Children under 2 years of age	Moderate to high transmission areas, %	Receiving cotrimoxazole, %	Receiving SMC, %	PMC eligible children	Population growth factor, %
Country	Children under 2 years of age	Moderate to high transmission areas, %	Receiving cotrimoxazole, %	Receiving SMC, %	PMC eligible children	2023–2024	2024–2025	2025–2026	2026–2027
Benin	836,737	100	0.16	2.5	814,472	1.9	1.8	1.9	1.5
Cameroon	1,767,234	100	0.29	17.0	1,461,599	1.5	1.5	1.5	1.3
Côte d'Ivoire	1,806,624	100	0.18	0.00	1,803,422	1.6	1.6	1.6	1.6
DRC	6,990,181	100	0.16	0.00	6,978,928	2.0	1.9	1.9	1.5
Mozambique	2,282,002	100	2.30	3.0	2,161,149	1.8	1.7	1.7	1.5
Nigeria	14,752,292	100	0.08	61.0	5,741,254	0.3	0.3	0.4	0.5
Sierra Leone	484,116	100	0.11	0.00	483,562	1.6	1.6	1.7	1.4
Togo	525,624	100	0.38	35.8	335,446	2.0	2.0	2.0	1.7
Zambia	1,311,086	100	1.60	0.00	1,290,145	3.1	2.7	2.6	1.1

ISSN: 1475-2875